ATLAS (AltaValve) Pivotal Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 450 participants.
Also called NCT06465745
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 450 participants
- Sponsor
- 4C Medical Technologies, Inc.
- Registry
-
NCT06465745
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Canada, France, Germany, Greece, Poland, Spain
- Registry status
- Recruiting
Technical summary
Registry record NCT06465745. Non-randomized; no masking; primary purpose treatment. Start 2024-09-03 (actual); primary completion 2029-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ATLAS (AltaValve) Pivotal Trial
- Acronym
- ATLAS
- Condition
- Mitral Regurgitation
- Condition
- Mitral Insufficiency
- Condition
- Mitral Valve Incompetence
- Condition
- Mitral Valve Regurgitation
- Condition
- Mitral Incompetence
- Intervention (Device)
- AltaValve System.
- Lead sponsor
- 4C Medical Technologies, Inc.
Record details
- Record id
cardio:ct-nct06465745- Content hash
f23621b29f94e2d840e4cbe870a06a35367938ecb22466d2d26cbead028ccb05